). In this cal and psychiatric diseases ranging from Parkinson's view, the primary action of dopamine is to activate neudisease to substance abuse, schizophrenia, and biporons through the D1 receptor, and this activation is lar disorders (for a complete list of studies, please go reduced by concurrent activation of the D2 receptor.
significantly improve the rodent's performance on the forced swim test. Human studies provide further support for a role of D2R in depression because some antidepressants act in part by blocking dopamine reuptake and by activating dopamine receptors. In addition, a compensatory upregulation of D2Rs has been observed in the striatum of patients suffering from depression. Taken together, these studies suggest that enhancing dopamine signaling might represent a promising complementary target to traditional antidepressants, especially when anhedonia and apathy are primary symptoms. The study by Beaulieu and colleagues provides evidence that a member of the D2R receptor subfamily inhibits the activity of the serine threonine kinase Akt through a β-arrestin 2-dependent mechanism and that this effect occurs through a newly discovered β-arrestin/kinase/phosphatase signaling complex ( Figure 1C ) that is independent from the traditional cAMP-dependent pathway. This suggests that β-arrestin plays a role in signal transduction, in addition to its canonical role in receptor internalization, through a complex composed of the intracellular proteins Akt, β-arrestin 2, and phosphatase PP2A. Combined with results from a previous study by the same group (Beaulieu et al., 2004), these results demonstrate that β-arrestin 2 is critical in 
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